These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 33325362

  • 1. [High expression of ICOS on CD4+ T cells and ICOSL on CD19+ B cells in peripheral blood and its positive correlation with TRAb in Graves' disease].
    Chen X, Wang F, Cong X, Shen Q, Chen L.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1102-1108. PubMed ID: 33325362
    [Abstract] [Full Text] [Related]

  • 2. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
    Bossowski A, Urban M, Stasiak-Barmuta A.
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
    [Abstract] [Full Text] [Related]

  • 3. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
    Yan X, Gu Y, Wang C, Sun S, Wang X, Tian J, Wang M, Ji X, Duan X, Gao H, Fang Q, Dong W, Zhang X, Xue Q.
    Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
    [Abstract] [Full Text] [Related]

  • 4. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
    Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K.
    Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
    [Abstract] [Full Text] [Related]

  • 5. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
    Wang F, Yan T, Chen L, Chen X, Liu T, Shen S, Li T, Gao L, Wang T, Sun J, Liu C, Wu H, Zhang X, Chen L.
    J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
    [Abstract] [Full Text] [Related]

  • 6. MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves' disease by targeting ICOS.
    Liu Y, Wang X, Luan W, Zou J, Xing J, Wang S, Peng H.
    Immunol Res; 2023 Apr; 71(2):173-184. PubMed ID: 36322282
    [Abstract] [Full Text] [Related]

  • 7. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production.
    Liu Z, Liu S, Zhang Y, Zeng W, Wang S, Ji P, Pan M, Zhu C, Wang Y.
    Cell Immunol; 2021 Oct; 368():104420. PubMed ID: 34418679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator.
    Jiao Q, Qian Q, Liu C, Luo Y, Fang F, Wang M, Ji J, Qian H, Zhang X, Maurer M.
    Br J Dermatol; 2020 Mar; 182(3):648-657. PubMed ID: 31090221
    [Abstract] [Full Text] [Related]

  • 10. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 11. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N, Zhou S, Liang Y, Xiao C, Shen H, Pan H, Deng H, Wang N, Li QQ.
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [Abstract] [Full Text] [Related]

  • 12. Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.
    Zhan XK, Liu XK, Zhang S, Chen H.
    Animal Model Exp Med; 2023 Oct; 6(5):464-473. PubMed ID: 37850501
    [Abstract] [Full Text] [Related]

  • 13. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS, Thibult ML, Just-Landi S, Pastor S, Gondois-Rey F, Granjeaud S, Broussais F, Bouabdallah R, Colisson R, Caux C, Ménétrier-Caux C, Leroux D, Xerri L, Olive D.
    Cancer Res; 2016 Aug 15; 76(16):4648-60. PubMed ID: 27246829
    [Abstract] [Full Text] [Related]

  • 14. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY, Ruan LB, Li Y, Yang TR, Liu WJ, Jiang YX, Li TR, Quan J, Xuan W.
    Eur Rev Med Pharmacol Sci; 2018 Dec 15; 22(24):8898-8908. PubMed ID: 30575933
    [Abstract] [Full Text] [Related]

  • 15. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T, Taniguchi H, Terada M, Akiba H, Yagita H, Abe R, Hori J.
    Invest Ophthalmol Vis Sci; 2016 Dec 01; 57(15):6815-6823. PubMed ID: 28002569
    [Abstract] [Full Text] [Related]

  • 16. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
    Zheng J, Chan PL, Liu Y, Qin G, Xiang Z, Lam KT, Lewis DB, Lau YL, Tu W.
    PLoS One; 2013 Dec 01; 8(12):e82203. PubMed ID: 24312642
    [Abstract] [Full Text] [Related]

  • 17. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
    Provera A, Ramavath NN, Gadipudi LL, Gigliotti CL, Boggio E, Vecchio C, Stoppa I, Rolla R, Boldorini R, Pirisi M, Smirne C, Albano E, Dianzani U, Sutti S.
    Front Immunol; 2023 Dec 01; 14():1290391. PubMed ID: 38077334
    [Abstract] [Full Text] [Related]

  • 18. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
    Ramavath NN, Gadipudi LL, Provera A, Gigliotti LC, Boggio E, Bozzola C, Albano E, Dianzani U, Sutti S.
    Front Immunol; 2021 Dec 01; 12():786680. PubMed ID: 34925367
    [Abstract] [Full Text] [Related]

  • 19. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
    Raineri D, Abreu H, Vilardo B, Kustrimovic N, Venegoni C, Cappellano G, Chiocchetti A.
    Int J Mol Sci; 2024 Feb 21; 25(5):. PubMed ID: 38473756
    [Abstract] [Full Text] [Related]

  • 20. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
    Wang F, Chen L, Shen Q, Liu T, Jiang L, Gu X, Chen L, Sun J, Liu C.
    Immunol Lett; 2015 May 21; 165(1):47-51. PubMed ID: 25839128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.